For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

USPTO Granted Patents = 12

% Expired Patents = 16.7

EPO Patents = 2

Trademarks = 2

Forward Citations = 24

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Patrick Y Lu (10 out of 21 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. David M Evans (3 out of 3 patents)

6. Alan Y Lu (2 out of 2 patents)

7. Xiaoyong Lu (2 out of 2 patents)

8. Dmitry Samarsky (2 out of 2 patents)

9. Qingfeng Li (1 out of 6 patents)

10. Yibin Cai (1 out of 1 patent)

11. Qing Ge (1 out of 1 patent)

12. Bojian Zheng (1 out of 6 patents)

13. Qingquan Tang (1 out of 1 patent)

14. Martin Woodle (1 out of 7 patents)

15. Jia Zhou (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12685775 - OLIGONUCLEOTIDES WITH NUCLEOSIDE ANALOGS (2026-07-21),

2. 12600967 - SiRNA compound that inhibits complement factor B (CFB) (2026-04-14),

3. 12378552 - Oligomeric compound for inhibiting expression of factor XI (2025-08-05),

4. 12054714 - Peptide docking vehicle for targeted nucleic acid delivery (2024-08-06),

5. 12006500 - Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) (2024-06-11),

6. 11697813 - Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis (2023-07-11),

7. 11058779 - Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection (2021-07-13),

8. RE46873 - Multi-targeted RNAi therapeutics for scarless wound healing of skin (2018-05-28),

9. 9868952 - Compositions and methods for 'resistance-proof' SiRNA therapeutics for influenza (2018-01-16),

10. 9642873 - Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application (2017-05-09),

11. 9506063 - SiRNA compositions and methods for treatment of HPV and other infections (2016-11-29),

12. 8691781 - Compositions for treating respiratory viral infections and their use (2014-04-08),

Sirnaomics, Inc. is a biotechnology company based in Gaithersburg, Maryland, specializing in the development of RNAi (RNA interference) therapeutics. The company focuses on innovative solutions for treating various diseases, leveraging its proprietary platform to design and manufacture RNA-based medicines. Sirnaomics aims to address unmet medical needs through its research in gene silencing technologies, with applications spanning oncology, liver diseases, and other therapeutic areas, positioning itself as a leader in the RNA therapeutics field.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#40 in Gaithersburg, MD

#353 in Maryland

#25,540 in US

#48,129 in the World

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

Forward Citations = 24

21 inventors:

Patrick Y Lu (10 out of 21 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. David M Evans (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…